Bank of America Increases American Healthcare REIT (NYSE:AHR) Price Target to $31.00

American Healthcare REIT (NYSE:AHR) had its price target lifted by investment analysts at Bank of America from $27.00 to $31.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Bank of America‘s price target would suggest a potential upside of 17.20% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. Truist Financial boosted their target price on American Healthcare REIT from $22.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, September 20th. KeyCorp increased their price objective on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday, September 16th. JMP Securities lifted their target price on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a research note on Friday, September 20th. Finally, Morgan Stanley increased their price target on shares of American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $23.00.

American Healthcare REIT Stock Performance

AHR stock opened at $26.45 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.29 and a current ratio of 0.29. American Healthcare REIT has a 52-week low of $12.63 and a 52-week high of $26.77. The company’s 50 day simple moving average is $20.02 and its 200-day simple moving average is $16.33.

American Healthcare REIT (NYSE:AHR) last announced its earnings results on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.28). The firm had revenue of $504.60 million for the quarter, compared to analyst estimates of $506.55 million. American Healthcare REIT had a negative net margin of 1.99% and a negative return on equity of 2.20%. American Healthcare REIT’s quarterly revenue was up 7.9% on a year-over-year basis. On average, equities research analysts anticipate that American Healthcare REIT will post 1.29 EPS for the current fiscal year.

Institutional Trading of American Healthcare REIT

Hedge funds have recently bought and sold shares of the stock. Manning & Napier Advisors LLC acquired a new position in shares of American Healthcare REIT during the second quarter valued at about $3,317,000. Quadrature Capital Ltd bought a new stake in shares of American Healthcare REIT in the 1st quarter worth approximately $914,000. Centersquare Investment Management LLC acquired a new stake in shares of American Healthcare REIT during the 1st quarter worth approximately $63,269,000. Capstone Investment Advisors LLC bought a new stake in shares of American Healthcare REIT in the 1st quarter worth about $1,201,000. Finally, Sei Investments Co. acquired a new stake in shares of American Healthcare REIT during the 1st quarter worth about $2,967,000. 16.68% of the stock is owned by institutional investors.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.